Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin in early stage HCC
NCT03219372Phase 2Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin in hepatocellular carcinoma (HCC), sponsored by Cedars-Sinai Medical Center. Started Sep 2018; status: terminated.
02
Drugs
pravastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03219372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219372.